Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
199.40    -3.20 (-1.58%)
Bid:
199.10
Ask:
199.70
Spread: 0.60 (0.301%)
Market Cap: £1.30b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Apr 2019 07:00

RNS Number : 2630W
Ashmore Group PLC
16 April 2019
 

Ashmore Group plc16 April 2019

THIRD QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 March 2019.

Assets under management

Theme

Actual31 December 2018

(US$ billion)

Estimated31 March 2019

(US$ billion)

Movement

(%)

External debt

15.5

16.7

+7.7%

Local currency

17.5

19.1

+9.1%

Corporate debt

10.8

14.1

+30.6%

Blended debt

20.4

22.0

+7.8%

Equities

4.4

4.7

+6.8%

Alternatives

1.6

1.6

-

Multi-asset

0.4

0.5

+25.0%

Overlay / liquidity

6.1

6.6

+8.2%

Total

76.7

85.3

+11.2%

 

Assets under management increased by US$8.6 billion during the period, through net inflows of US$5.0 billion and positive investment performance of US$3.6 billion.

Client demand remains strong and broad-based across investment themes, with net inflows in the corporate debt, local currency, overlay/liquidity, blended debt and external debt investment themes. Institutional flows continue to be biased towards existing clients, including additional allocations to large mandates in the corporate debt and overlay/liquidity themes. There was ongoing momentum in mutual fund flows, particularly in Europe and the US, with continued interest in the short duration, local currency bond and blended debt strategies.

Absolute performance levels were highest in the blended debt and external debt themes, and despite US dollar strength in the latter part of the period, local currency and equities delivered good returns over the three months. Corporate debt and multi-asset also produced positive performance. Ashmore's relative investment performance remains strong over three and five years, and the consistent implementation of its investment processes means that one year performance versus benchmarks has, as expected, improved strongly over the quarter.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Client activity levels picked up through the quarter following a slight pause at the end of 2018. This reflects a number of ongoing positive factors including investors' light positioning in Emerging Markets, the significant value available across a diverse range of investment themes, and slowing growth and political challenges in the developed world. The increasing diversity of Ashmore's product range enables flows to be captured at different points in the cycle. These factors, together with the delivery of strong performance across the investment themes, mean Ashmore is well-positioned for continued growth."

 

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingNeil Doyle +44 (0)20 3727 1141Laura Ewart +44 (0)20 3727 1160

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFSRSSIELIA
Date   Source Headline
10th Apr 20147:00 amRNSInterim Management Statement
9th Apr 20142:13 pmRNSHolding(s) in Company
8th Apr 20142:47 pmRNSHolding(s) in Company
28th Mar 20145:30 pmRNSDirector/PDMR Shareholding
3rd Mar 20145:48 pmRNSHolding(s) in Company
28th Feb 20147:00 amRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSHalf Yearly Report
24th Feb 20143:14 pmRNSHolding(s) in Company
14th Jan 20147:00 amRNSQ2 AuM Statement
6th Jan 20148:36 amRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSDirectorate Change
30th Oct 20132:51 pmRNSResult of AGM
29th Oct 20135:00 pmRNSAnnual Information Update
21st Oct 201312:03 pmRNSDirector/PDMR Shareholding
10th Oct 20137:00 amRNSInterim Management Statement
30th Sep 20135:08 pmRNSNotice of AGM
18th Sep 20134:40 pmRNSDirector/PDMR Shareholding
18th Sep 20134:36 pmRNSDirector/PDMR Shareholding
10th Sep 20137:00 amRNSFinal Results
2nd Aug 20134:28 pmRNSHolding(s) in Company
11th Jul 20137:00 amRNSQ4 AuM Statement
9th Jul 20135:43 pmRNSHolding(s) in Company
3rd Jul 20135:03 pmRNSDirector/PDMR Shareholding
24th Jun 20136:28 pmRNSHolding(s) in Company
21st Jun 20133:33 pmRNSHolding(s) in Company
17th Jun 20133:25 pmRNSHolding(s) in Company
13th Jun 20134:05 pmRNSHolding(s) in Company
7th Jun 201311:20 amRNSHolding(s) in Company
24th Apr 20137:00 amRNSCapital Markets Day
11th Apr 20137:00 amRNSInterim Management Statement
25th Mar 20134:30 pmRNSDirector/PDMR Shareholding
21st Mar 201311:36 amRNSHolding(s) in Company
22nd Feb 20134:30 pmRNSDirector/PDMR Shareholding
21st Feb 20137:00 amRNSHalf Yearly Report
19th Feb 20132:06 pmRNSAppointment of Directors
4th Dec 20125:30 pmRNSDirector/PDMR Shareholding
31st Oct 20124:38 pmRNSResult of AGM
26th Oct 20128:48 amRNSAnnual Information Update
11th Oct 20127:00 amRNSInterim Management Statement
1st Oct 20124:24 pmRNSNotice of AGM
21st Sep 20124:20 pmRNSDirector/PDMR Shareholding
11th Sep 20127:00 amRNSFinal Results
12th Jul 20127:00 amRNSTrading Statement
12th Apr 20127:00 amRNSInterim Management Statement
30th Mar 20126:01 pmRNSHolding(s) in Company
30th Mar 20126:00 pmRNSDirector/PDMR Shareholding
27th Feb 20125:10 pmRNSHolding(s) in Company
23rd Feb 20127:00 amRNSHalf Yearly Report
16th Feb 20125:58 pmRNSHolding(s) in Company
10th Feb 20127:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.